Lovastatin Potentiates the Function of α7-Nicotinic Acetylcholine Receptors
Pharmaceuticals · 29.05.2026 · 19 (6) · 849
DOI: 10.3390/ph19060849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 29.05.2026. Verfasst von Dmytro Isaev und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Membranology, Bogomoletz Institute of Physiology, 01024 Kiev, Ukraine. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported and funded by the Research Sector of the Kuwait University, Research Project No. PT 03/21., Research Sector of the Kuwait University.
Abstract (Originalsprache)
Background/Objectives: Statins are currently one of the most commonly used cholesterol-lowering drugs. In recent years, in addition to their well-known effects on the cardiovascular system, statins have been shown to exert beneficial effects in the progression of various neuropsychiatric and neurodegenerative diseases.
Methods
In this study, the effects of lovastatin on the function of α7-nicotinic acetylcholine (nACh) receptors expressed in rat hippocampus and Xenopus oocytes were investigated.
Results
In whole-cell patch clamp studies in hippocampal neurons, 21-day chronic (20 mg/kg), but not acute (20 min), lovastatin treatment caused significant potentiation of choline (a selective agonist for α7 nACh receptors)-induced currents and choline-induced increases in GABAA receptor-mediated currents. Further studies in Xenopus oocytes expressing human α7-nACh receptors indicated that 72 h pretreatment with lovastatin caused a significant increase in α7-nACh receptor function with an EC50 value of 296 nM. Other statins, such as simvastatin and pravastatin, also potentiated α7-nACh receptors. Potentiation by lovastatin treatment was associated with a significant decrease in oocyte cholesterol content and was diminished by Go6983, an inhibitor of protein kinase C (PKC), suggesting that both decreased cholesterol levels and activation of PKC are involved in statin potentiation of α7-nACh receptors.
Conclusions
In conclusion, our findings indicate that chronic lovastatin treatment potentiates the function of α7-nACh receptors in hippocampal neurons and in Xenopus oocytes expressing human α7-nACh receptors and provides important insights that could guide future efforts to design novel drugs targeting α7-nACh receptors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cellular Membranology, Bogomoletz Institute of Physiology, 01024 Kiev, Ukraine.
- Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, CA 92866, USA.
- Department of Pharmacology and Therapeutics, College of Pharmacy, Kuwait University, Safat 13110, Kuwait.
ORCID-Profile: Keun-Hang Susan Yang, Murat Oz
Förderung
- This work was supported and funded by the Research Sector of the Kuwait University, Research Project No. PT 03/21.
- Research Sector of the Kuwait University
Zitieren
APA
Isaev, D., Yang, K. S., & Oz, M. (2026). Lovastatin Potentiates the Function of α7-Nicotinic Acetylcholine Receptors. Pharmaceuticals, 19(6), 849. https://doi.org/10.3390/ph19060849
Vancouver
Isaev D, Yang KS, Oz M. Lovastatin Potentiates the Function of α7-Nicotinic Acetylcholine Receptors. Pharmaceuticals. 2026;19(6):849. doi:10.3390/ph19060849
BibTeX
@article{Isaev2026,
author = {Isaev, Dmytro and Yang, Keun-Hang Susan and Oz, Murat},
title = {Lovastatin Potentiates the Function of α7-Nicotinic Acetylcholine Receptors},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {849},
doi = {10.3390/ph19060849}
}
EUVIMED